There are a number of barriers to glycaemic control in type 1 diabetes, including the occurrence and fear of hypoglycaemia and the complexity and demands of day-to-day management, in particular the need for frequent self-monitoring of blood glucose (SMBG) and regular adjustments in insulin dosing. This evidence concerns the gene INS and type 1 diabetes mellitus.